Your browser doesn't support javascript.
loading
Thyroid Cancer Screening Using Tumor-Associated DN T Cells as Immunogenomic Markers.
Imam, Shahnawaz; Paparodis, Rodis D; Rafiqi, Shafiya Imtiaz; Ali, Sophia; Niaz, Azra; Kanzy, Abed; Tovar, Yara E; Madkhali, Mohammed A; Elsherif, Ahmed; Khogeer, Feras; Zahid, Zeeshan A; Sarwar, Haider; Karim, Tamanna; Salim, Nancy; Jaume, Juan C.
Afiliação
  • Imam S; Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, College of Medicine and Life Sciences, University of Toledo, Toledo, OH, United States.
  • Paparodis RD; Center for Diabetes and Endocrine Research (CeDER), University of Toledo, Toledo, OH, United States.
  • Rafiqi SI; Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, College of Medicine and Life Sciences, University of Toledo, Toledo, OH, United States.
  • Ali S; Center for Diabetes and Endocrine Research (CeDER), University of Toledo, Toledo, OH, United States.
  • Niaz A; Private Practitioner, Patras, Greece.
  • Kanzy A; Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, College of Medicine and Life Sciences, University of Toledo, Toledo, OH, United States.
  • Tovar YE; Center for Diabetes and Endocrine Research (CeDER), University of Toledo, Toledo, OH, United States.
  • Madkhali MA; Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, College of Medicine and Life Sciences, University of Toledo, Toledo, OH, United States.
  • Elsherif A; Center for Diabetes and Endocrine Research (CeDER), University of Toledo, Toledo, OH, United States.
  • Khogeer F; Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, College of Medicine and Life Sciences, University of Toledo, Toledo, OH, United States.
  • Zahid ZA; Center for Diabetes and Endocrine Research (CeDER), University of Toledo, Toledo, OH, United States.
  • Sarwar H; Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, College of Medicine and Life Sciences, University of Toledo, Toledo, OH, United States.
  • Karim T; Center for Diabetes and Endocrine Research (CeDER), University of Toledo, Toledo, OH, United States.
  • Salim N; Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, College of Medicine and Life Sciences, University of Toledo, Toledo, OH, United States.
  • Jaume JC; Center for Diabetes and Endocrine Research (CeDER), University of Toledo, Toledo, OH, United States.
Front Oncol ; 12: 891002, 2022.
Article em En | MEDLINE | ID: mdl-35692772

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article